Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients - A prospective study with 115 examinations

被引:200
|
作者
Sommer, Torsten
Naehle, Claas P.
Yang, Alexander
Zeijlemaker, Volkert
Hackenbroch, Matthias
Schmiedel, Alexandra
Meyer, Carsten
Strach, Katharina
Skowasch, Dirk
Vahlhaus, Christian
Litt, Harold
Schild, Hans
机构
[1] Univ Bonn, Dept Radiol, Cardiovasc Imaging Sect, D-53127 Bonn, Germany
[2] Univ Bonn, Dept Cardiol, D-53127 Bonn, Germany
[3] Medtron Bakker Res Ctr, Maastricht, Netherlands
[4] Hosp Univ Muenster, Dept Cardiol & Angiol, Munster, Germany
[5] Univ Penn, Sch Med, Dept Radiol, Philadelphia, PA 19104 USA
关键词
magnetic resonance imaging; pacemakers; safety; imaging;
D O I
10.1161/CIRCULATIONAHA.105.597013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The purpose of the present study was to evaluate a strategy for safe performance of extrathoracic magnetic resonance imaging (MRI) in non-pacemaker-dependent patients with cardiac pacemakers. Methods and Results-Inclusion criteria were presence of a cardiac pacemaker and urgent clinical need for an MRI examination. Pacemaker-dependent patients and those requiring examinations of the thoracic region were excluded. The study group consisted of 82 pacemaker patients who underwent a total of 115 MRI examinations at 1.5T. To minimize radiofrequency-related lead heating, the specific absorption rate was limited to 1.5 W/kg. All pacemakers were reprogrammed before MRI: If heart rate was < 60 bpm, the asynchronous mode was programmed to avoid magnetic resonance (MR)-induced inhibition; if heart rate was > 60 bpm, sense-only mode was used to avoid MR-induced competitive pacing and potential proarrhythmia. Patients were monitored with ECG and pulse oximetry. All pacemakers were interrogated immediately before and after the MRI examination and after 3 months, including measurement of pacing capture threshold (PCT) and serum troponin I levels. All MR examinations were completed safely. Inhibition of pacemaker output or induction of arrhythmias was not observed. PCT increased significantly from pre- to post-MRI (P = 0.017). In 2 of 195 leads, an increase in PCT was only detected at follow-up. In 4 of 114 examinations, troponin increased from a normal baseline value to above normal after MRI, and in 1 case (troponin pre-MRI 0.02 ng/mL, post-MRI 0.16 ng/mL), this increase was associated with a significant increase in PCT. Conclusions-Extrathoracic MRI of non-pacemaker-dependent patients can be performed with an acceptable risk-benefit ratio under controlled conditions and by taking both MR-and pacemaker-related precautions.
引用
收藏
页码:1285 / 1292
页数:8
相关论文
共 10 条
  • [1] Saftey of magnetic resonance imaging in patients with cardiac pacemakers: A prospective study in 115 patients at 1.5 Tesla
    Becker, Alexander
    Muehling, Olaf
    Hinterseer, Martin
    Morhard, Dominilk
    Relthmann, Christopher
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A3 - A3
  • [2] Magnetic Resonance Imaging at 1.5 Tesla in Patients with Cardiac Pacemakers: A prospective study in 388 patients
    Becker, Alexander
    Muehling, Olaf
    Gleixner, Julia
    Morhard, Dominik
    Wakili, Reza
    Brueckmann, Hartmut
    Knez, Andreas
    CIRCULATION, 2010, 122 (21)
  • [3] Artefacts in 1.5 Tesla and 3 Tesla cardiac magnetic resonance imaging in patients with leadless cardiac pacemakers
    Kiblboeck, D.
    Reiter, C.
    Kammler, J.
    Schmit, P.
    Blessberger, H.
    Kellermair, J.
    Lukas, T.
    Kypta, A.
    Fellner, F.
    Steinwender, C.
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 113 - 113
  • [4] Artefacts in 1.5 Tesla and 3 Tesla cardiovascular magnetic resonance imaging in patients with leadless cardiac pacemakers
    Daniel Kiblboeck
    Christian Reiter
    Juergen Kammler
    Pierre Schmit
    Hermann Blessberger
    Joerg Kellermair
    Franz Fellner
    Clemens Steinwender
    Journal of Cardiovascular Magnetic Resonance, 20
  • [5] Artefacts in 1.5 Tesla and 3 Tesla cardiovascular magnetic resonance imaging in patients with leadless cardiac pacemakers
    Kiblboeck, Daniel
    Reiter, Christian
    Kammler, Juergen
    Schmit, Pierre
    Blessberger, Hermann
    Kellermair, Joerg
    Fellner, Franz
    Steinwender, Clemens
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2018, 20
  • [6] Preliminary findings on the safety of 1.5 and 3 Tesla magnetic resonance imaging in cardiac pacemaker patients
    van Dijk, Vincent F.
    Delnoy, Peter Paul H. M.
    Smit, Jaap Jan J.
    Misier, R. Anand Ramdat
    Elvan, Arif
    van Es, H. Wouter
    Rensing, Benno J. W. M.
    Raciti, Giovanni
    Boersma, Lucas V. A.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2017, 28 (07) : 806 - 810
  • [7] Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers
    Gimbel, JR
    Johnson, D
    Levine, PA
    Wilkoff, BL
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (06): : 913 - 919
  • [8] Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable- cardioverter defibrillators at 1.5 tesla
    Nazarian, Saman
    Roguin, Ariel
    Zviman, Menekhem M.
    Lardo, Albert C.
    Dickfeld, Timm L.
    Calkins, Hugh
    Weiss, Robert G.
    Berger, Ronald D.
    Bluemke, David A.
    Halperin, Henry R.
    CIRCULATION, 2006, 114 (12) : 1277 - 1284
  • [9] Determining the Risks of Magnetic Resonance Imaging at 1.5 Tesla for Patients with Non-MRI Conditional Pacemakers and Implantable Cardioverter Defibrillators: Final Results of The MagnaSafe Registry
    Russo, Robert J.
    CIRCULATION, 2014, 130 (23) : 2118 - 2118
  • [10] Performance of comprehensive cardiac magnetic resonance imaging including T1 and T2 mapping on 1.5 vs. 3.0 Tesla as compared to biventricular endomyocardial biopsy in patients with suspected myocarditis - the MyoRacer trial
    Philipp Lurz
    Christian F Luecke
    Marcus Sandri
    Enno Boudriot
    Ingo Eitel
    Suzanne de Waha
    Karin Klingel
    Reinhard Kandolf
    Matthias Grothoff
    Gerhard Schuler
    Holger Thiele
    Matthias Gutberlet
    Journal of Cardiovascular Magnetic Resonance, 18 (Suppl 1)